epoxyketone tetrapeptide
Carfilzomib companies
Answer
Public registers name 3 licence holders, 23 ingredient makers with a drug master file, 11 bulk ingredient labelers, 2 US labelers, 149 trial sponsors and 2 recalling firms for Carfilzomib.
Each row is what a register states. A company named here is not endorsed or accused by this site.
MARKETING AUTHORISATION HOLDER
3 companies
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| AMGEN CANADA INC | KYPROLIS (DIN 02451034), Marketed Regulator Health Canada KYPROLIS (DIN 02459930), Marketed Regulator Health Canada KYPROLIS (DIN 02459949), Marketed Regulator Health Canada |
|---|---|
| Amgen Europe B.V. | Kyprolis (EMEA/H/C/003790), Authorised Regulator EMA |
| AMGEN LIMITED | KYPROLIS (CARFILZOMIB) 10 MG POWDER FOR SOLUTION FOR INFUSION, PLGB 13832/0023, Authorised Regulator MHRA KYPROLIS (CARFILZOMIB) 30 MG POWDER FOR SOLUTION FOR INFUSION, PLGB 13832/0024, Authorised Regulator MHRA KYPROLIS (CARFILZOMIB) 60 MG POWDER FOR SOLUTION FOR INFUSION, PLGB 13832/0025, Authorised Regulator MHRA |
API MANUFACTURER
23 companies
Filed a drug master file with FDA for the active ingredient.
| BIOPHORE INDIA PHARMACEUTICALS PVT LTD | DMF 32406, type II, active, submitted 2017-12-30 Regulator FDA drug master file list |
|---|---|
| CHONGQING CARELIFE PHARMACEUTICAL CO LTD | DMF 38180, type II, active, submitted 2023-05-18 Regulator FDA drug master file list |
| CHONGQING MIDECO PHARMACEUTICAL CO LTD | DMF 41199, type II, active, submitted 2025-01-23 Regulator FDA drug master file list |
| CHONGQING PHARMACEUTICAL RESEARCH INSTITUTE CO LTD | DMF 30162, type II, inactive, submitted 2015-12-29 Regulator FDA drug master file list |
| CHONGQING SINTAHO PHARMACEUTICAL CO LTD | DMF 40891, type II, active, submitted 2025-03-11 Regulator FDA drug master file list |
| CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD | DMF 31276, type II, inactive, submitted 2016-12-30 Regulator FDA drug master file list |
| DR REDDYS LABORATORIES LTD | DMF 30402, type II, active, submitted 2016-03-29 Regulator FDA drug master file list |
| FRESENIUS KABI ONCOLOGY LTD | DMF 29750, type II, inactive, submitted 2016-01-30 Regulator FDA drug master file list |
| HETERO LABS LTD | DMF 40268, type II, active, submitted 2025-02-24 Regulator FDA drug master file list |
| INTAS PHARMACEUTICALS LTD | DMF 35083, type II, active, submitted 2020-09-08 Regulator FDA drug master file list |
| JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD | DMF 41263, type II, active, submitted 2025-03-10 Regulator FDA drug master file list |
| JIANGSU XIDI PHARMACEUTICALS CO LTD | DMF 38486, type II, active, submitted 2023-09-06 Regulator FDA drug master file list |
| LAURUS LABS LTD | DMF 30115, type II, active, submitted 2016-03-22 Regulator FDA drug master file list |
| LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD | DMF 41029, type II, active, submitted 2025-01-17 Regulator FDA drug master file list |
| MSN LABORATORIES PRIVATE LTD | DMF 29671, type II, active, submitted 2015-08-29 Regulator FDA drug master file list |
| POLYMED THERAPEUTICS INC | DMF 30357, type II, active, submitted 2016-02-26 Regulator FDA drug master file list |
| QILU PHARMACEUTICAL CO LTD | DMF 29770, type II, active, submitted 2015-09-28 Regulator FDA drug master file list |
| SEACROSS PHARMA USA INC | DMF 38169, type II, inactive, submitted 2023-04-03 Regulator FDA drug master file list |
| SHANDONG NEW TIME PHARMACEUTICAL CO LTD | DMF 38290, type II, active, submitted 2023-05-16 Regulator FDA drug master file list |
| SICHUAN HUIYU PHARMACEUTICAL CO LTD | DMF 40758, type II, active, submitted 2024-11-25 Regulator FDA drug master file list |
| TAPI NL BV | DMF 30124, type II, active, submitted 2016-01-21 Regulator FDA drug master file list |
| TONGSHENG PHARMACEUTICAL (JINGMEN) CO LTD | DMF 42402, type II, active, submitted 2025-08-21 Regulator FDA drug master file list DMF 42852, type II, active, submitted 2025-10-24 Regulator FDA drug master file list |
| WISDOM PHARMACEUTICAL CO LTD | DMF 43372, type II, active, submitted 2025-12-31 Regulator FDA drug master file list |
BULK INGREDIENT LABELER
11 companies
Lists the bulk active ingredient with FDA (NDC directory).
| Apicore pharmaceuticals private limited | Carfilzomib, BULK INGREDIENT Regulator openFDA |
|---|---|
| Chunghwa Chemical Synthesis & Biotech. Ltd | Carfilzomib, BULK INGREDIENT Regulator openFDA |
| Dr.Reddys Laboratories Limited | Carfilzomib, BULK INGREDIENT Regulator openFDA |
| HAS Healthcare Advanced Synthesis SA | Carfilzomib, BULK INGREDIENT Regulator openFDA |
| HETERO LABS LIMITED | Carfilzomib, BULK INGREDIENT Regulator openFDA |
| JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD | Carfilzomib, BULK INGREDIENT Regulator openFDA |
| LAURUS LABS LIMITED | CARFILZOMIB, BULK INGREDIENT Regulator openFDA |
| LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD | Carfilzomib, BULK INGREDIENT Regulator openFDA |
| MSN Laboratories Private Limited | Carfilzomib, BULK INGREDIENT Regulator openFDA |
| Sionc Pharmaceutical Private Limited | CARFILZOMIB, BULK INGREDIENT Regulator openFDA |
| TAPI Croatia Industries Ltd. | Carfilzomib, BULK INGREDIENT Regulator openFDA |
US LABELER
2 companies
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
| Onyx Pharmaceuticals, Inc. | KYPROLIS, NDA Regulator openFDA |
|---|---|
| Patheon Manufacturing Services LLC | Carfilzomib, DRUG FOR FURTHER PROCESSING Regulator openFDA |
TRIAL SPONSOR
149 companies
Sponsors registered clinical trials of the peptide.
| Amgen | 27 registered trials Trial register ClinicalTrials.gov |
|---|---|
| National Cancer Institute (NCI) | 11 registered trials Trial register ClinicalTrials.gov |
| M.D. Anderson Cancer Center | 9 registered trials Trial register ClinicalTrials.gov |
| University of Chicago | 9 registered trials Trial register ClinicalTrials.gov |
| Janssen Research & Development, LLC | 6 registered trials Trial register ClinicalTrials.gov |
| Mayo Clinic | 6 registered trials Trial register ClinicalTrials.gov |
| AbbVie | 5 registered trials Trial register ClinicalTrials.gov |
| Emory University | 5 registered trials Trial register ClinicalTrials.gov |
| European Myeloma Network B.V. | 5 registered trials Trial register ClinicalTrials.gov |
| Hackensack Meridian Health | 5 registered trials Trial register ClinicalTrials.gov |
| Memorial Sloan Kettering Cancer Center | 5 registered trials Trial register ClinicalTrials.gov |
| Oncotherapeutics | 5 registered trials Trial register ClinicalTrials.gov |
| Sanofi | 5 registered trials Trial register ClinicalTrials.gov |
| Celgene | 4 registered trials Trial register ClinicalTrials.gov |
| PETHEMA Foundation | 4 registered trials Trial register ClinicalTrials.gov |
| PFIZER | 4 registered trials Trial register ClinicalTrials.gov |
| Roswell Park Cancer Institute | 4 registered trials Trial register ClinicalTrials.gov |
| Wake Forest University Health Sciences | 4 registered trials Trial register ClinicalTrials.gov |
| AbbVie Deutschland GmbH & Co. KG | 3 registered trials Trial register EU CTIS |
| Celgene Corp. | 3 registered trials Trial register EU CTIS |
| Criterium, Inc. | 3 registered trials Trial register ClinicalTrials.gov |
| Fundacion PETHEMA | 3 registered trials Trial register EU CTIS |
| The First Affiliated Hospital of Soochow University | 3 registered trials Trial register ClinicalTrials.gov |
| University of Alabama at Birmingham | 3 registered trials Trial register ClinicalTrials.gov |
| University of Washington | 3 registered trials Trial register ClinicalTrials.gov |
| Washington University School of Medicine | 3 registered trials Trial register ClinicalTrials.gov |
| Central Hospital, Nancy, France | 2 registered trials Trial register ClinicalTrials.gov |
| Dong-A University Hospital | 2 registered trials Trial register ClinicalTrials.gov |
| Hoffmann-La Roche | 2 registered trials Trial register ClinicalTrials.gov |
| Karyopharm Therapeutics Inc | 2 registered trials Trial register ClinicalTrials.gov |
| Massachusetts General Hospital | 2 registered trials Trial register ClinicalTrials.gov |
| Nantes University Hospital | 2 registered trials Trial register ClinicalTrials.gov |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 registered trials Trial register ClinicalTrials.gov |
| Oslo University Hospital | 2 registered trials Trial register ClinicalTrials.gov |
| Regeneron Pharmaceuticals | 2 registered trials Trial register ClinicalTrials.gov |
| Samsung Medical Center | 2 registered trials Trial register ClinicalTrials.gov |
| Sanofi-Aventis Recherche & Developpement | 2 registered trials Trial register EU CTIS |
| SCRI Development Innovations, LLC | 2 registered trials Trial register ClinicalTrials.gov |
| Tel-Aviv Sourasky Medical Center | 2 registered trials Trial register ClinicalTrials.gov |
| Universitätsklinikum Hamburg-Eppendorf | 2 registered trials Trial register ClinicalTrials.gov |
Showing 40 of 149.
RECALLING FIRM
2 companies
Recalled a product naming the peptide (FDA enforcement report).
| Amgen, Inc. | Class II recall, Terminated, 2016-12-28 Regulator openFDA |
|---|---|
| Infusion Options, Inc. | Class II recall, Terminated, 2019-08-21 Regulator openFDA |
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.